Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis-Reference-Cited by-同舟云学术

Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease Prophylaxis

Published:2017-09 Issue:9 Volume:23 Page:1549-1554
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Castagna Luca,Mussetti Alberto^ORCID,Devillier Raynier,Dominietto Alida,Marcatti Magda,Milone Giuseppe,Maura Francesco,de Philippis Chiara,Bruno Benedetto,Furst Sabine,Blaise Didier,Corradini Paolo,Montefusco Vittorio

Funder

AIL

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Donor leukocyte infusions for multiple myeloma;Salama;Bone Marrow Transplant,2000

2. Allogeneic stem cell transplantation for multiple myeloma: is there a future?;Dhakal;Bone Marrow Transplant,2016

3. Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults;Kasamon;J Clin Oncol,2015

4. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

5. Haploidentical hematopoietic stem-cell transplantation in adults;Alshemmari;Bone Marrow Res,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31

2. Allogeneic stem cell transplantation in multiple myeloma: is there still a place?;Frontiers in Oncology;2024-06-04

3. An Update on Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma;Recent Updates on Multiple Myeloma;2023-03-15

4. Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years;Anticancer Research;2022-12

5. Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma;Oncology and Therapy;2022-04-04